arrow
S

Shahid Zaman

university of cambridge
H指数:36
被引数:5,500

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Inflammation Associated With Obesity, Aging, and Amyloid Burden in Adults With Down Syndrome

肥胖、衰老及淀粉样蛋白负荷与唐氏综合征成人炎症的相关性

Obesity
IF4.7
2026-06-050
OA
Imaging and plasma biomarkers for pathological accumulation in Down syndrome

Down综合征中病理积聚的成像和血浆生物标志物

Brain
IF11.7
2025-11-050
PRE
Development and evaluation of image preprocessing pipelines for the Centiloid method on Down Syndrome data

基于Down Syndrome数据对Centiloid方法图像预处理流程的开发与评估

2025-10-110
OAAI
Alzheimer's disease diagnostic progression is associated with cerebrovascular disease and neuroinflammation in adults with Down syndrome

阿尔茨海默病诊断进展与唐氏综合征成人中的脑血管疾病及神经炎症相关

2025-09-270
OAAI
Cross-Sectional FDG in Down Syndrome and Autosomal Dominant Alzheimer's Disease

横断面FDG在唐氏综合征和常染色体显性阿尔茨海默病中的应用

2025-09-220
PRE
Prediction of amyloid and tau brain deposition and cognitive decline in people with Down syndrome using plasma biomarkers: a longitudinal cohort study

使用血浆生物标志物预测唐氏综合征患者中淀粉样蛋白和tau蛋白脑沉积及认知衰退:一项纵向队列研究

2025-06-180
OA
The striatum is an early, accurate indicator of amyloid burden using [11C]PiB in Down syndrome: Comparison of two radiotracers

纹状体是使用[11C]PiB检测唐氏综合征中淀粉样蛋白负荷的早期、准确指标:两种放射性示踪剂的比较

2025-04-060
OAAI
Validation of the CAMCOG-DS-II, a neuropsychological test battery for Alzheimer's disease in people with Down syndrome: A Horizon 21 European Down syndrome Consortium study

CAMCOG-DS-II神经心理学测试量表的验证:一种用于唐氏综合征患者的阿尔茨海默病的测试量表——一项Horizon 21欧洲唐氏综合征联盟研究

2025-03-270
OA
Mitochondrial Dysfunction Correlates with Brain Amyloid Binding, Memory, and Executive Function in Down Syndrome: Implications for Alzheimer's Disease in Down Syndrome

线粒体功能障碍与唐氏综合征中的脑淀粉样蛋白结合、记忆力和执行功能相关:对唐氏综合征中阿尔茨海默病的启示

2025-01-281
OA
The effects of mosaicism on biological and clinical markers of Alzheimer's disease in adults with Down syndrome

嵌合体对唐氏综合征成人阿尔茨海默病生物学和临床标志物的影响

2024-12-010
OAAI
The mediating role of plasma glial fibrillary acidic protein in amyloid and tau pathology in Down's syndrome

血浆胶质纤维酸性蛋白在唐氏综合征淀粉样蛋白和tau病理中的介导作用

2024-11-130
OAAI
Cerebrovascular disease is associated with Alzheimer's plasma biomarker concentrations in adults with Down syndrome

患有唐氏综合症的成年人的脑血管疾病与阿尔茨海默氏症的血浆生物标志物浓度相关

2024-09-251
OAAI
Cognitive and functional performance and plasma biomarkers of early Alzheimer's disease in Down syndrome

唐氏综合征早期阿尔茨海默病的认知和功能表现及血浆生物标志物

2024-04-142
OAAI
Adapting prescribing criteria for amyloid-targeted antibodies for adults with Down syndrome

调整唐氏综合症成人淀粉样蛋白靶向抗体的处方标准

2024-03-135
OA
Down Syndrome Biobank Consortium: A perspective
2024-01-254
OA
Timing of Alzheimer's Disease by Intellectual Disability Level in Down Syndrome

唐氏综合症中智力残疾水平对阿尔茨海默氏病的发病时间

2023-07-173
OAAI
Association of biological sex with clinical outcomes and biomarkers of Alzheimer's disease in adults with Down syndrome

唐氏综合症成人的生物学性别与阿尔茨海默病的临床结局和生物标志物的关联

2023-03-1717
OAAI